ArticleInternational journal of surgery (London, England)2026

CD36 serves as a signaling receptor and free fatty acid (FFA) transporter in dyslipidemia: the role of dapagliflozin and alirocumab in downregulating atherogenic dyslipidemia via FFA uptake inhibition-experimental study.

Jui-Ning Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.